Skip to main content
Log in

Summary

Metabolites of CBD excreted into the bile and perfusion fluid were examined in a rat liver perfusion preparation. Metabolites were extracted with ethyl acetate and identified by GC/MS as TMS derivatives. Four mono- and five di-hydroxy metabolites were identified with major sites of metabolic attack being at C-7 and C-4″. A hydroxy-ketone was detected but not fully identified. All biliary metabolites were conjugated with glucuronic acid. Urinary metabolites were studied in rats with samples taken at times to 25 h after drug administration. Unmetabolized CBD and 13 metabolites were identified by GC/MS. Major metabolites were acids with beta-oxidation being a prominent pathway. The 6- and 7-hydroxy derivatives of 4″, 5″-bis,nor-CBD-3″-oic acid were the most abundant compounds but substantial concentrations of the di-acids, CBD-5″,7-dioic acid and 4″,5″-bis,nor-CBD-3″,7-dioic acid were present. Concentrations of the more highly oxidized metabolites increased with time.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Turner C.E., ElSohly M.A., Boeren E.G. (1980): Constituents ofCannabis sativa L., XVII. A review of the natural constituents. J. Nat Prods., 43, 169–234.

    Article  CAS  Google Scholar 

  2. Razdan R.K. (1986): Structure-activity relationships in cannabinoids. Pharmacol. Rev., 38, 75–149.

    CAS  PubMed  Google Scholar 

  3. Consroe P., Snider S.R. (1986): Therapeutic potential of cannabinoids in neurological disorders. In: Mechoulam R. Ed. Cannabinoids as Therapeutic Agents. Boca Raton, CRC Press, pp. 21–49.

    Google Scholar 

  4. Martin B., Nordqvist M., Agurell S., Lindgren J.-E., Leander N., Binder M. (1976): Identification of monohydroxylated metabolites of cannabidiol formed by a rat liver. J. Pharm. Pharmacol., 28, 275–279.

    CAS  PubMed  Google Scholar 

  5. Martin B, Agurell S., Nordqvist M., Lindgren J.-E. (1976): Dioxygenated metabolites of cannabidiol formed by rat liver. J. Pharm. Pharmacol., 28, 603–608.

    CAS  PubMed  Google Scholar 

  6. Martin B.R., Harvey D.J., Paton W.D.M. (1977): Biotransformation of cannabidiol in mice: identification of new acid metabolites. Drug Metab. Dispos., 5, 259–267.

    CAS  PubMed  Google Scholar 

  7. Harvey D.J., Martin B.R., Paton W.D.M. (1980): Identification of in vivo liver metabolites of delta-1-tetrahydro-cannabinol, cannabidiol and cannabinol produced by the guinea pig. J. Pharm. Pharmacol., 32, 267–271.

    CAS  PubMed  Google Scholar 

  8. Robertson L.W., Huff S.R., Ghosh A., Malhottra R. (1978): Acidic biotransformation products of cannabinoids produced byMycobacterium rhodochrous. Lloydia, 41, 659.

    Google Scholar 

  9. Robertson L.W., Koh S.W., Huff S.R., Malhottra R.K. (1978): Microbiological oxidation of the pentyl side-chain of cannabinoids. Experientia, 34, 1020–1022.

    Article  CAS  PubMed  Google Scholar 

  10. Samara E., Bialer M., Harvey D.J. (1990): Identification of urinary metabolites of cannabidiol in the dog. Drug Metab. Dispos., 18, 1065–1076.

    Google Scholar 

  11. Harvey D.J., Mechoulam R. (1990): Metabolites of cannabidiol identified in human urine. Xenobiotica, 20, 303–320.

    Article  CAS  PubMed  Google Scholar 

  12. Harvey D.J., Paton W.D.M. (1984): Metabolism of the cannabinoids. Rev. Biochem. Toxicol., 6, 221–264.

    CAS  Google Scholar 

  13. Meijer D.K.F., Keulemans K., Mulder G.J. (1981): Isolated perfused rat liver technique. Methods Enzymol., 77, 81–94.

    Article  CAS  PubMed  Google Scholar 

  14. Harvey D.J., Martin B.R., Paton W.D.M. (1977): Identification of di- and tri-substituted hydroxy and ketone metabolites of delta-1-tetrahydrocannabinol in mouse liver. J. Pharm. Pharmacol., 29, 482–486.

    CAS  PubMed  Google Scholar 

  15. McCloskey J.A., Stillwell R.N., Lawson A.M. (1968): Use of deuterium labelled trimethylsilyl derivatives in mass spectrometry. Anal. Chem., 40, 233–236.

    Article  CAS  Google Scholar 

  16. Harvey D.J. (1987): Mass spectrometry of the cannabinoids and their metabolites. Mass Spectrom. Rev., 6, 135–229.

    Article  CAS  Google Scholar 

  17. Binder M., Agurell S., Leander K., Lindgren J.-E. (1974): Zur Identifikation potentieller Metabolite von Cannabis-Inhaltstoffen: Kernresonanz und massenspektropische Untersuchungen an seitenkettenhydroxylierten Cannabinoiden. Helv. Chim. Acta, 579, 1626–1641.

    Article  Google Scholar 

  18. Harvey D.J. (1981): The mass spectra of the trimethylsilyl derivatives of the hydroxy and acid metabolites of delta-1- and delta-6-tetrahydrocannabinol. Biomed. Mass Spectrom., 8, 579–588.

    Article  CAS  PubMed  Google Scholar 

  19. Samara E., Bialer M., Harvey D.J. (1990): Identification of glucose conjugates as the major urinary metabolites of cannabidiol in the dog. Xenobiotica, 20, 177–183.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Samara, E., Bialer, M. & Harvey, D.J. Metabolism of cannabidiol by the rat. European Journal of Drug Metabolism and Pharmacokinetics 16, 305–313 (1991). https://doi.org/10.1007/BF03189976

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03189976

Keywords

Navigation